Taken together, while these natural products exhibit potential biological activity relevant to DOR, current evidence remains preliminary and largely exploratory
The Guidelines are intended to give an understanding of a clinical problem, and outline one or more preferred approaches to the investigation and management of the problem
Developmental synaptic regulator, TWEAK/Fn14 signaling, is a determinant of synaptic function in models of stroke and neurodegeneration
Pineal peptides do not have the extensive clinical trial data that pharmaceutical sleep aids do
Arbaclofen, a GABA B agonist, has recently emerged as a potential therapeutic for ASD
Procurement Insights: Sourcing, Pricing, and Supplier Selection for Cagrilintide For pharmaceutical businesses, research institutions, and contract development organizations, getting a steady source of high-quality peptides is essential to their success